Salivary protein biomarkers for head and neck cancer

No Thumbnail Available
File version
Author(s)
Amenabar, Jose M
Da Silva, Bruna Machado
Punyadeera, Chamindie
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2020
Size
File type(s)
Location
License
Abstract

Introduction: Saliva has gained attention as an important diagnostic fluid because it contains biomolecules that have the potential to detect early-stage cancer or to monitor the response to treatment in patients. Several saliva-based proteins have been proposed as potential biomarkers for head and neck cancers (HNC). Areas covered: This review aims to provide an update on saliva-based protein biomarkers for HNC, often studied in observational research and clinical trials. Expert opinion: Despite the increasing number of studies relating to salivary proteins as biomarkers for HNC, there is no consensus regarding which proteins have the best clinical utility. Most studies have analyzed individual proteins and not a protein panel approach. It must be considered that combining different proteins as a panel can increase the accuracy and will have the potential to change the current clinical practice for HNC patients.

Journal Title

Expert Review of Molecular Diagnostics

Conference Title
Book Title
Edition
Volume

20

Issue

3

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Oncology and carcinogenesis

Predictive and prognostic markers

Science & Technology

Life Sciences & Biomedicine

Pathology

Saliva

proteins

Persistent link to this record
Citation

Amenabar, JM; Da Silva, BM; Punyadeera, C, Salivary protein biomarkers for head and neck cancer, Expert Review of Molecular Diagnostics, 2020, 20 (3), pp. 305-313

Collections